Taken together, these data suggest a requirement for IRE1α and XBP1 in many processes that affect glucose-mediated stimulation of insulin production by β cells—a finding that could strongly impact efforts to target this pathway for treatment of diabetes mellitus. This evidence concerns the gene INS and diabetes mellitus.